These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
204 related items for PubMed ID: 1874015
21. Antimalarial properties of Goniothalamin in combination with chloroquine against Plasmodium yoelii and Plasmodium berghei growth in mice. Mohd Ridzuan MA, Ruenruetai U, Noor Rain A, Khozirah S, Zakiah I. Trop Biomed; 2006 Dec; 23(2):140-6. PubMed ID: 17322815 [Abstract] [Full Text] [Related]
22. Toward a novel metal-based chemotherapy against tropical diseases. 3. Synthesis and antimalarial activity in vitro and in vivo of the new gold-chloroquine complex [Au(PPh3)(CQ)]PF6. Navarro M, Pérez H, Sánchez-Delgado RA. J Med Chem; 1997 Jun 06; 40(12):1937-9. PubMed ID: 9191972 [No Abstract] [Full Text] [Related]
23. Synthesis and antimalarial property of orally active phenoxazinium salts. Takasu K, Shimogama T, Satoh C, Kaiser M, Brun R, Ihara M. J Med Chem; 2007 May 17; 50(10):2281-4. PubMed ID: 17441706 [Abstract] [Full Text] [Related]
24. Antimalarial effect of agmatine on Plasmodium berghei K173 strain. Su RB, Wei XL, Liu Y, Li J. Acta Pharmacol Sin; 2003 Sep 17; 24(9):918-22. PubMed ID: 12956942 [Abstract] [Full Text] [Related]
25. The chemotherapy of rodent malaria. XLIV. Studies on the mode of action of CM 6606, an indolo (3,2-c) quinoline N-oxide. Peters W, Robinson BL, Mutambu SL, Warhurst DC, Ellis DS, Tovey DG. Ann Trop Med Parasitol; 1989 Feb 17; 83(1):1-10. PubMed ID: 2688575 [Abstract] [Full Text] [Related]
26. Plasmodium berghei: dehydroepiandrosterone sulfate reverses chloroquino-resistance in experimental malaria infection; correlation with glucose 6-phosphate dehydrogenase and glutathione synthesis pathway. Safeukui I, Mangou F, Malvy D, Vincendeau P, Mossalayi D, Haumont G, Vatan R, Olliaro P, Millet P. Biochem Pharmacol; 2004 Nov 15; 68(10):1903-10. PubMed ID: 15476661 [Abstract] [Full Text] [Related]
27. [Sensitivity of Plasmodium falciparum to piperaquine in Baoting County, Hainan Island]. Huang JZ, Lan XH, Xu WZ. Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1985 Nov 15; 3(4):276-7. PubMed ID: 3915732 [No Abstract] [Full Text] [Related]
28. Synthesis and in vitro and in vivo antimalarial activity of N1-(7-chloro-4-quinolyl)-1,4-bis(3-aminopropyl)piperazine derivatives. Ryckebusch A, Deprez-Poulain R, Maes L, Debreu-Fontaine MA, Mouray E, Grellier P, Sergheraert C. J Med Chem; 2003 Feb 13; 46(4):542-57. PubMed ID: 12570376 [Abstract] [Full Text] [Related]
29. Curcumin for malaria therapy. Reddy RC, Vatsala PG, Keshamouni VG, Padmanaban G, Rangarajan PN. Biochem Biophys Res Commun; 2005 Jan 14; 326(2):472-4. PubMed ID: 15582601 [Abstract] [Full Text] [Related]
30. The antimalarial activity of N-benzyl-oxydihydrotriazines. III. The activity of 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(2,4,5,-trichloropropyloxy)-1,3,5-triazine hydrobromide (BRL 51084) and hydrochloride (BRL 6231). Knight DJ, Mamalis P, Peters W. Ann Trop Med Parasitol; 1982 Feb 14; 76(1):1-7. PubMed ID: 7044322 [No Abstract] [Full Text] [Related]
31. The antimalarial activity of N-benzyloxydihydrotriazines. I. The activity of clociguanil (BRL 50216) against rodent malaria, and studies on its mode of action. Knight DJ, Peters W. Ann Trop Med Parasitol; 1980 Aug 14; 74(4):393-404. PubMed ID: 7006531 [No Abstract] [Full Text] [Related]
33. Antimalarial activity of 4-amidinoquinoline and 10-amidinobenzonaphthyridine derivatives. Korotchenko V, Sathunuru R, Gerena L, Caridha D, Li Q, Kreishman-Deitrick M, Smith PL, Lin AJ. J Med Chem; 2015 Apr 23; 58(8):3411-31. PubMed ID: 25654185 [Abstract] [Full Text] [Related]
34. Design, synthesis, and structure-activity relationship studies of 4-quinolinyl- and 9-acrydinylhydrazones as potent antimalarial agents. Fattorusso C, Campiani G, Kukreja G, Persico M, Butini S, Romano MP, Altarelli M, Ros S, Brindisi M, Savini L, Novellino E, Nacci V, Fattorusso E, Parapini S, Basilico N, Taramelli D, Yardley V, Croft S, Borriello M, Gemma S. J Med Chem; 2008 Mar 13; 51(5):1333-43. PubMed ID: 18278859 [Abstract] [Full Text] [Related]
35. [Evaluation of the Plasmodium falciparum response to chloroquine, quinine and mefloquine]. Di Santi SM, Camargo Neves VL, Boulos M, Dutra AP, Ramos AM, Santos M, Barata LC. Rev Inst Med Trop Sao Paulo; 1988 Mar 13; 30(3):147-52. PubMed ID: 3065907 [No Abstract] [Full Text] [Related]
36. Studies on the resistance to single and combined antimalarials in the Plasmodium berghei mouse model. Merkli B, Richle RW. Acta Trop; 1980 Sep 13; 37(3):228-31. PubMed ID: 6106358 [No Abstract] [Full Text] [Related]
37. Synthesis and evaluation of sulfonylurea derivatives as novel antimalarials. León C, Rodrigues J, Gamboa de Domínguez N, Charris J, Gut J, Rosenthal PJ, Domínguez JN. Eur J Med Chem; 2007 Jun 13; 42(6):735-42. PubMed ID: 17321641 [Abstract] [Full Text] [Related]
38. Antimalarial dual drugs based on potent inhibitors of glutathione reductase from Plasmodium falciparum. Friebolin W, Jannack B, Wenzel N, Furrer J, Oeser T, Sanchez CP, Lanzer M, Yardley V, Becker K, Davioud-Charvet E. J Med Chem; 2008 Mar 13; 51(5):1260-77. PubMed ID: 18260613 [Abstract] [Full Text] [Related]
39. In vitro mefloquine resistance of Plasmodium falciparum isolated from the Burmese border region of Thailand. Childs GE, Pang L, Wimonwattrawatee T, Pooyindee N, Nanakorn A, Limchitee S, Webster HK. Southeast Asian J Trop Med Public Health; 1987 Dec 13; 18(4):438-43. PubMed ID: 3329409 [Abstract] [Full Text] [Related]